EA60 - Some Skin Conditions Attributable to Fungal Infection: Complete Coding Guide

1. Introduction

Skin conditions caused by fungal infections represent a diverse and clinically relevant group of dermatological conditions that affect millions of people worldwide. The EA60 code from the International Classification of Diseases (ICD-11) was developed specifically to categorize both localized fungal infections of the skin and systemic fungal infections that present with significant cutaneous manifestations.

This group of conditions ranges from common superficial infections, such as pityriasis versicolor caused by yeasts of the genus Malassezia, to severe systemic infections such as cutaneous cryptococcosis, which may indicate significant immunological compromise. The prevalence of these conditions varies according to climatic factors, socioeconomic status, and population characteristics, being particularly frequent in regions with tropical and subtropical climates.

The clinical importance of cutaneous fungal infections transcends aesthetic or symptomatic discomfort. Often, cutaneous manifestations of fungal infections may be the first sign of underlying systemic conditions or immunological compromise, making their recognition essential for early diagnosis and appropriate treatment. Furthermore, some fungal infections can cause significant morbidity when not treated adequately, leading to chronic or recurrent complications.

Correct coding of these conditions is critical for multiple purposes: it enables appropriate epidemiological tracking, facilitates appropriate resource allocation in health systems, aids in pharmacovigilance and antimicrobial resistance studies, and ensures correct reimbursement of diagnostic and therapeutic procedures. Accurate coding also contributes to effective communication between health professionals and institutions, improving continuity of care.

2. Correct ICD-11 Code

Code: EA60

Description: Some skin conditions attributable to fungal infection

Parent category: null - Some skin conditions attributable to infection or infestation

Official definition: This group includes both localized skin infection by fungus (e.g., pityriasis versicolor) and systemic fungal infections with important cutaneous manifestations (e.g., cutaneous cryptococcosis).

The code EA60 represents a comprehensive category within the ICD-11 structure, designed to capture the diversity of clinical presentations of fungal infections affecting the skin. The classification recognizes that fungi can cause skin disease through two main mechanisms: direct and localized infection of skin tissues, or as a manifestation of a disseminated systemic fungal infection.

This categorization is particularly important because it reflects the clinical reality where some fungal infections remain confined to the skin and its appendages, while others represent manifestations of potentially serious diseases that require systemic investigation and more aggressive treatment. The code structure allows healthcare professionals to quickly identify cases that require more thorough evaluation regarding the patient's immunological status.

3. When to Use This Code

Code EA60 should be used in specific clinical situations where there is confirmation or strong suspicion of fungal infection with cutaneous manifestations. Below, we present detailed practical scenarios:

Scenario 1: Confirmed Pityriasis Versicolor Patient presents with hypochromic or hyperchromic macules, mainly on the trunk, with fine scaling. Direct mycological examination with potassium hydroxide reveals characteristic "spaghetti and meatballs" structures of Malassezia. This is a classic example of localized superficial fungal infection that justifies the use of code EA60.

Scenario 2: Intertriginous Cutaneous Candidiasis Patient with diabetes mellitus develops erythematous and macerated lesions in areas of skin folds (axillae, inguinal region, inframammary), with characteristic satellite lesions. Mycological culture confirms Candida albicans. This presentation of localized fungal infection with specific cutaneous manifestations should be coded with EA60.

Scenario 3: Cutaneous Cryptococcosis Immunocompromised patient presents with papulous, nodular, or ulcerated skin lesions, with skin biopsy confirming infection by Cryptococcus neoformans. This scenario represents a systemic fungal infection with important cutaneous manifestations, fitting perfectly within the definition of code EA60.

Scenario 4: Cutaneous Sporotrichosis Patient with history of skin trauma from plant material develops a subcutaneous nodule that evolves with nodular lesions along a lymphatic tract (lymphocutaneous pattern). Culture in specific medium identifies Sporothrix schenckii. This fungal infection with characteristic cutaneous manifestation requires code EA60.

Scenario 5: Cutaneous Histoplasmosis Patient with history of exposure to contaminated environments develops papulonodular, ulcerated, or verrucous cutaneous lesions, with histopathological and mycological confirmation of Histoplasma capsulatum. This cutaneous manifestation of systemic fungal infection should be coded with EA60.

Scenario 6: Atypical or Extensive Dermatophytosis Patient presents with extensive cutaneous lesions caused by dermatophytes, confirmed by direct mycological examination and culture, especially when there is involvement of multiple body areas or atypical presentation that requires specific documentation of the fungal infection.

In all these scenarios, the essential criterion is confirmation or strong clinical evidence of fungal etiology of the cutaneous condition, whether localized or manifestation of systemic disease.

4. When NOT to Use This Code

It is fundamental to recognize situations where code EA60 is not appropriate, avoiding coding errors that may compromise epidemiological records and administrative processes:

Viral Skin Infections: Conditions such as herpes simplex, herpes zoster, viral warts, or molluscum contagiosum should not be coded with EA60, as they have a specific code for skin conditions attributable to viral infection. Viral etiology is fundamentally different from fungal etiology, requiring distinct diagnostic and therapeutic approaches.

Bacterial Skin Infections: Impetigo, erysipelas, cellulitis, bacterial folliculitis, and other infections caused by bacteria should be coded with the specific code for skin conditions attributable to bacterial infection. Even when there is secondary bacterial superinfection in a fungal lesion, coding should reflect the primary etiological agent or both, when appropriate.

Parasitic Infestations: Scabies, pediculosis, cutaneous larva migrans, and other parasitic infestations have a specific code and should not be confused with fungal infections, despite some potentially presenting with similar cutaneous manifestations.

Non-Infectious Dermatitis: Conditions such as atopic dermatitis, psoriasis, seborrheic dermatitis (except when there is evidence of secondary infection by Malassezia), lichen planus, and other non-infectious inflammatory dermatoses should not receive code EA60, even when they present with scaling or changes that may resemble fungal infections.

Allergic or Drug Reactions: Skin eruptions caused by allergic reactions, toxicodermas, or drug reactions should not be coded as fungal infections, even when the initial clinical presentation may be confusing.

Appropriate differentiation requires careful clinical evaluation, frequently complemented by specific laboratory tests such as direct mycological examination, fungal culture, or histopathology.

5. Step-by-Step Coding Process

Step 1: Assess Diagnostic Criteria

The first essential step is to confirm that the cutaneous condition has fungal etiology. This requires:

Detailed Clinical Evaluation: Carefully examine the morphological characteristics of cutaneous lesions. Fungal infections frequently present specific patterns: raised borders with cleared center in dermatophytosis, hypochromic or hyperchromic macules with fine scaling in pityriasis versicolor, erythematous lesions with maceration and satellite lesions in candidiasis.

Complementary Examinations: Direct mycological examination with potassium hydroxide is fundamental for visualization of fungal structures. Culture in specific medium allows identification of the etiological agent. In cases of suspected systemic fungal infection with cutaneous manifestation, cutaneous biopsy with histopathological examination and tissue culture may be necessary. Molecular methods such as PCR can be utilized in specific cases.

Clinical History: Investigate predisposing factors such as use of immunosuppressants, diabetes mellitus, specific environmental exposure, previous cutaneous trauma, and patient's immunological status.

Step 2: Verify Specifiers

After confirming fungal etiology, evaluate:

Disease Extension: Determine whether the infection is localized (limited to a specific area) or disseminated (multiple areas or manifestation of systemic disease). This distinction is crucial for clinical management and may require additional coding.

Severity: Assess the depth of involvement (superficial versus deep), presence of complications such as ulceration or secondary infection, and functional or aesthetic impact.

Etiological Agent: When identified, the specific agent may require complementary or more specific coding within available subcategories.

Duration: Classify as acute, subacute, or chronic, as this may influence both treatment and prognosis.

Step 3: Differentiate from Other Codes

null: Some skin conditions attributable to viral infection The key difference lies in the etiological agent. Viral infections generally present vesicles, umbilicated papules, or characteristic verrucous lesions, while fungal infections typically show scaling, maceration, or nodular lesions. Direct microscopic examination and cultures are definitive for differentiation.

null: Some skin conditions attributable to bacterial infection Bacterial infections frequently present faster progression, with more pronounced inflammatory signs (heat, redness, pain), presence of pustules or meliceric crusts. Gram staining and bacterial culture definitively differentiate from fungal infections.

null: Some parasitic infections or infestations affecting the skin Parasitic infestations such as scabies present intense pruritus with specific distribution pattern and presence of characteristic burrows. Direct parasitological examination identifies the parasite, differentiating from fungal infections.

Step 4: Required Documentation

For adequate coding, the medical record must contain:

Checklist of Mandatory Information:

Detailed description of cutaneous lesions (morphology, distribution, extension)
Results of mycological examinations performed (direct, culture, histopathology)
Identification of fungal agent when available
Predisposing factors or relevant comorbidities
Assessment of systemic involvement when applicable
Treatment instituted and therapeutic response
Clear justification of fungal etiology

Adequate Record: Documentation must be sufficiently detailed to allow another professional to understand the diagnostic reasoning and justification for the chosen coding.

6. Complete Practical Example

Clinical Case:

A 45-year-old female patient presents to dermatology consultation with a complaint of "spots on the trunk" for approximately three months. She reports that the lesions started as small spots that progressively increased in size. She denies intense itching but reports fine scaling when scratching. She does not present systemic symptoms such as fever or weight loss.

On physical examination, multiple hypochromic and hyperchromic macules are observed with well-defined borders, predominantly on the anterior and posterior trunk, neck region, and proximal portion of the upper limbs. The lesions present fine scaling on curettage. There are no signs of acute inflammation, vesicles, or pustules. The remainder of the dermatologic examination reveals no other significant changes.

Past medical history reveals that the patient resides in a tropical climate region with elevated temperature and humidity. She denies use of immunosuppressive medications, is not diabetic, and does not present other significant comorbidities. She reports working in an environment with heat exposure and perspires abundantly.

Material was collected from the lesions through skin scraping for direct mycologic examination. The examination with 10% potassium hydroxide revealed the presence of short hyphae and round yeast cells grouped together, with a characteristic appearance of "spaghetti and meatballs," compatible with Malassezia spp.

Coding Step by Step:

Criteria Analysis:

Confirmation of fungal etiology: The direct mycologic examination confirmed the presence of fungal structures characteristic of Malassezia, definitively establishing the fungal etiology of the skin condition.
Characterization of infection: This is a superficial fungal infection localized to the skin, without evidence of systemic involvement. The clinical and laboratory presentation is consistent with pityriasis versicolor.
Exclusion of other etiologies: The absence of vesicles, pustules, or signs of secondary bacterial infection, associated with the mycologic examination result, excludes viral, bacterial, or parasitic etiologies.
Evaluation of specifiers: Superficial infection, chronic (three months of evolution), without complications, involving multiple body areas.

Code Selected: EA60 - Some skin conditions attributable to fungal infection

Complete Justification:

The code EA60 is appropriate for this case because:

There is laboratory confirmation of fungal infection through direct mycologic examination
Pityriasis versicolor is specifically mentioned in the code definition as an example of localized skin infection by fungus
The clinical presentation is typical of superficial fungal infection
There is no evidence of systemic infection requiring additional coding
The condition does not fall into exclusion categories (viral, bacterial, or parasitic)

Complementary Codes:

Depending on the coding system used and the need for additional specification, complementary codes may be considered to document the specific etiologic agent (Malassezia spp.) or the precise anatomic location, if available in the system.

7. Related Codes and Differentiation

Within the Same Category:

null: Some skin conditions attributable to viral infection

When to use vs. EA60: This code should be used when the etiology of the skin condition is viral, not fungal. Examples include herpes simplex, herpes zoster, warts caused by human papillomavirus, molluscum contagiosum, and viral exanthems.

Main difference: The fundamental differentiation lies in the etiologic agent. Viral infections frequently present with vesicles (grouped in herpes), umbilicated papules (molluscum contagiosum), or verrucous lesions. Microscopic examination and molecular diagnostic methods confirm the viral nature. Fungal infections typically show scaling, hyphae on direct examination, and growth in fungal-specific cultures.

null: Some skin conditions attributable to bacterial infection

When to use vs. EA60: Use this code when there is confirmation of bacterial skin infection, such as impetigo, erysipelas, cellulitis, bacterial folliculitis, or other pyodermas.

Main difference: Bacterial infections generally present with more acute progression, with prominent inflammatory signs (intense erythema, local warmth, pain), presence of pustules, honey-crusted lesions, or purulent exudate. Gram staining and bacterial culture identify the agent. Fungal infections tend to have more insidious progression, with scaling as a prominent feature and confirmation by mycologic examination.

null: Some parasitic infections or infestations affecting the skin

When to use vs. EA60: This code is appropriate for ectoparasite infestations (scabies, pediculosis) or parasitic infections affecting the skin (cutaneous larva migrans, cutaneous leishmaniasis).

Main difference: Parasitic infestations such as scabies present with intense pruritus, especially nocturnal, with lesions in characteristic locations and visualization of burrows or the parasite itself on direct examination. Fungal infections rarely cause pruritus of the same intensity and are confirmed by visualization of fungal structures, not parasitic ones.

Differential Diagnoses:

Pityriasis Alba: Can be confused with pityriasis versicolor, but does not present fungal structures on direct mycologic examination. Generally occurs in children and is associated with atopic dermatitis.

Vitiligo: The depigmented lesions of vitiligo are completely achromic (without melanin), in contrast to the hypochromic lesions of pityriasis versicolor which present with scaling and fungal structures on examination.

Seborrheic Dermatitis: Although colonization by Malassezia may occur, seborrheic dermatitis is classified as an inflammatory dermatosis, not infectious, unless there is clear evidence of secondary fungal infection.

8. Differences with ICD-10

In ICD-10, cutaneous fungal infections were classified primarily in the chapter of infectious and parasitic diseases, with specific codes for different types of mycoses. For example, pityriasis versicolor was coded as B36.0, while other superficial mycoses had distinct codes within the B35-B36 category.

The main change in ICD-11 with code EA60 is the creation of a more comprehensive category that unifies both localized fungal infections and cutaneous manifestations of systemic infections. This approach better reflects the clinical reality where the skin can be affected by fungi through different mechanisms.

Practical Impact:

The structure of ICD-11 facilitates coding by creating a clear category for all cutaneous conditions of fungal etiology, regardless of whether they are localized or systemic. This simplifies the coding process and improves consistency among different coders. Furthermore, the new structure allows for better epidemiological tracking of fungal infections with cutaneous manifestations.

Healthcare professionals familiar with ICD-10 should be aware of this conceptual change, recognizing that code EA60 encompasses conditions that were previously distributed across different sections of the classification. The transition requires adequate training and understanding of the new organizational logic of ICD-11.

9. Frequently Asked Questions

1. How is the diagnosis of cutaneous fungal infections made?

Diagnosis generally begins with detailed clinical evaluation of skin lesions. Direct mycological examination with potassium hydroxide is the most common and rapid method to confirm the presence of fungal structures. Culture in specific medium (such as Sabouraud) allows identification of the etiological agent, although it takes more time. In cases of suspected deep or systemic fungal infection, skin biopsy with histopathological examination and tissue culture may be necessary. Molecular methods such as PCR are available in specialized centers for rapid and accurate identification.

2. Is treatment available in public health systems?

Yes, most antifungal agents used to treat cutaneous infections are available in public health systems in various countries. Topical treatments such as antifungal creams and solutions are generally accessible and effective for superficial infections. For more extensive or refractory infections, oral antifungals are also available, although they may require specialized prescription. Specific access may vary according to each health system's structure and regional availability.

3. How long does treatment last?

Treatment duration varies significantly depending on the type of fungal infection and its extent. Superficial infections such as pityriasis versicolor may respond to topical treatments within one to four weeks. Cutaneous candidiasis generally requires treatment for two to four weeks. Dermatophytoses may require four to eight weeks of treatment, especially when there is nail involvement. Deep or systemic fungal infections with cutaneous manifestations may require months of treatment with systemic antifungals.

4. Can this code be used in medical certificates?

Yes, the code EA60 can and should be used in official medical documentation, including certificates, when appropriate. However, it is important to consider that medical certificates generally also require clear description of the condition in understandable language. Coding serves for standardization and record-keeping, but does not replace clear communication with the patient and other professionals about the diagnosis and its implications.

5. Are cutaneous fungal infections contagious?

Transmissibility varies depending on the type of fungal infection. Dermatophytoses (tineas) can be transmitted by direct person-to-person contact or through contaminated fomites. Cutaneous candidiasis is generally not considered highly contagious, as Candida is part of normal microbiota. Pityriasis versicolor is not considered contagious, as Malassezia is also part of normal skin microbiota. Systemic fungal infections with cutaneous manifestations are generally not transmissible from person to person.

6. Is it necessary to abstain from activities during treatment?

In most cases of superficial fungal infections, there is no need to abstain from routine activities, including work or school. Exceptions may occur in cases of extensive, painful infections or when there is specific occupational risk of transmission (such as healthcare professionals with hand lesions). The decision should be individualized, considering the nature of the infection, the patient's occupation, and the risk of transmission.

7. Can cutaneous fungal infections indicate immunological problems?

While common superficial fungal infections can occur in immunocompetent individuals, certain presentations should alert to possible immunodeficiency. Recurrent, extensive, treatment-refractory fungal infections or those caused by opportunistic fungi (such as cutaneous cryptococcosis) should prompt investigation of immunological status, including evaluation for diabetes mellitus, HIV infection, or other immunosuppressive conditions.

8. What is the difference between fungal infection and colonization?

Colonization refers to the presence of fungi on the skin without causing disease or symptoms, which is normal for many fungi such as Malassezia and Candida. Infection occurs when there is tissue invasion, inflammatory response, and clinical manifestations. This distinction is important because not all presence of fungi requires treatment. The diagnosis of fungal infection should be based on correlation between clinical and laboratory findings, not merely on fungal detection.

Conclusion:

The code EA60 from ICD-11 represents an essential tool for appropriate coding of cutaneous conditions of fungal etiology, ranging from localized superficial infections to cutaneous manifestations of systemic infections. Proper understanding of when to use this code, how to differentiate it from other conditions, and how to document appropriately is fundamental for healthcare professionals involved in dermatological care and medical coding. Correct application of this code contributes to accurate epidemiological records, effective communication between professionals, and appropriate resource management in health systems globally.

External References

This article was prepared based on reliable scientific sources:

References verified on 2026-02-03

Some Skin Conditions Attributable to Fungal Infection

Compartir